This work proposes the use of nonporous, smart, and stimulus responsive chitosan-based scaffolds for bone tissue engineering applications. The overall vision is to use biodegradable scaffolds based on chitosan and starch that present properties that will be regulated by bone regeneration, with the capability of gradual in situ pore formation. Biomimetic calcium phosphate (CaP) coatings were used as a strategy to incorporate lysozyme at the surface of chitosan-based materials with the main objective of controlling and tailoring their degradation profile as a function of immersion time. To confirm the concept, degradation tests with a lysozyme concentration similar to that incorporated into CaP chitosan-based scaffolds were used to study the degradation of the scaffolds and the formation of pores as a function of immersion time. Degradation studies with lysozyme (1.5 g=L) showed the formation of pores, indicating an increase of porosity (*5-55% up to 21 days) resulting in porous threedimensional structures with interconnected pores. Additional studies investigated the influence of a CaP biomimetic coating on osteogenic differentiation of rat marrow stromal cells (MSCs) and showed enhanced differentiation of rat MSCs seeded on the CaP-coated chitosan-based scaffolds with lysozyme incorporated. At all culture times, CaP-coated chitosan-based scaffolds with incorporated lysozyme demonstrated greater osteogenic differentiation of MSCs, bone matrix production, and mineralization as demonstrated by calcium deposition measurements, compared with controls (uncoated scaffolds). The ability of these CaP-coated chitosan-based scaffolds with incorporated lysozyme to create an interconnected pore network in situ coupled with the demonstrated positive effect of these scaffolds upon osteogenic differentiation of MSCs and mineralized matrix production illustrates the strong potential of these scaffolds for application in bone tissue engineering strategies.
Introduction
T issue engineering strategies include two general categories: (1) the use of acellular matrices (artificial scaffolds or decellularized tissues), which depend upon the natural ability of the body to regenerate for proper orientation and direction of new tissue growth, and (2) the use of scaffolds with cells. 1, 2 The typical strategy involves the use of a porous scaffold, which serves as a transplantation vehicle for cultured cells and a template to guide tissue regeneration, thereby playing an important role in transforming the cell-seeded scaffold into a new tissue. To allow a high density of colonizing cells and to promote neovascularization when implanted in vivo, the scaffolds should have high porosity, large surface area, mechanical properties and pore sizes appropriate for the application, and a highly interconnected pore structure. 1 In addition, biocompatibility and biodegradability are also required properties. Bone regeneration is a complex series of events involving proliferation and differentiation of mesenchymal stem cells into osteoblasts, bone matrix production, and mineralization.
As extensively described in the literature, scaffold porosity is inversely related to the mechanical properties of the scaffold; thus, it is necessary to balance the mechanical needs of the particular tissue that is going to be replaced and the scaffold porosity sufficient to allow tissue growth. 4, 5 Therefore, this work proposes the use of nonporous scaffolds composed of an in vivo responsive material that will be regulated by bone regeneration, with gradual in situ pore formation and consequent scaffold resorption. 6 This novel approach includes the use of smart and stimulus responsive scaffolds that might be intelligent enough to control their degradation profile as a function of implantation time and to induce osteogenic differentiation of marrow stromal cells (MSCs).
Chitosan has been considered to be a promising material for tissue engineering applications. [7] [8] [9] It is a linear copolymer of N-acetyl-D-glucosamine and D-glucosamine, derived from the deacetylation of chitin. The deacetylation degree measures the percentage of glucosamine units in the polymer chain and influences its physicochemical properties such as solubility, crystallinity, swelling behavior, and biological properties, 10 such as osteogenesis enhancement. [11] [12] [13] The Nacetylglucosamine present in chitosan is also responsible for nitric oxide production by rat peritoneal exudate macrophages 14 at reasonable levels in terms of inflammatory response but very effective in terms of wound tissue repair. 15 It has also been demonstrated that chitosan is degraded in vitro and in vivo by lysozyme, [15] [16] [17] an enzyme ubiquitous in the human body. Moreover, hydrolytic actions of lysozyme are able to activate macrophages and to promote collagen deposition. The biocompatibility of chitosan might be attributed to its structural similarity to glycosaminoglycan, which is a major component of the extracellular matrix (ECM) of bone and cartilage. 12 Starch was used as a component of the scaffolds presented in this study as a sacrifice material that will be easily degraded by several enzymes occurring in the human body. 6 Several in vitro and in vivo studies have shown that starchbased biomaterials are biocompatible [18] [19] [20] and biodegradable. 6, 21, 22 The main enzymes involved in starch degradation are a-amylases, b-amylases, a-glucosidases, glucoamylases, and other debranching enzymes (pullulanase and isoamylase). 23, 24 The enzymatic degradation products of starch hydrolysis are mainly glucose, maltose, and dextrin. 24 A potential method to enhance the bone bonding, osteoconductive, and=or osteoinductive capacity of chitosan and starch-based scaffolds is to apply on the surface of the threedimensional (3D) structures a calcium phosphate (CaP) biomimetic coating with a composition similar to the major inorganic component of bone, hydroxyapatite. In addition, biomimetic CaP coatings have been considered as potential carriers of bioactive proteins without compromising their activity, as they are generated under physiological conditions (pH 7.4, 378C). 22, [25] [26] [27] [28] It has been shown that different proteins can be directly integrated into the structure of CaP coatings without compromising their activity, and their release is mainly controlled by the dissolution mechanism of the coating. 22, [25] [26] [27] In this sense, biomimetic coatings were used to tailor the material surface properties or to directly enhance cell adhesion, proliferation, and osteogenic differentiation. Moreover, CaP coatings are used as a means to functionalize biomaterials with biological affinity and protein adsorption properties, as previously mentioned. 28 The incorporation of different enzymes into CaP coatings, prepared on the surface of scaffolds by means of a biomimetic coating technique, seems to be a very interesting strategy to control their degradation rate. In this work, lysozyme was incorporated into the coatings with the aim of developing a self-regulating degradable material with a capacity for gradual in situ pore formation. In addition, this system can simultaneously exhibit osteoinductive and osteoconductive properties in the sense that it can act as a carrier system for the controlled release of multiple biologically active proteins. In the past decade, a large number of publications showed osteoinduction by CaP coatings in several animal models. 29, 30 Recent research has shown that the biological performance of osteoinductive biomaterials, namely, on new bone growth orthotopically, is significantly better than nonosteoinductive biomaterials. 30 The present study reports the use of CaP-coated chitosanbased scaffolds with incorporated lysozyme. This study was designed to answer the following questions: (1) How does lysozyme influence the formation of pores in chitosan scaffolds, using a similar concentration to the one incorporated into CaP coatings? (2) Does this concentration of lysozyme allow the formation of interconnected pores? (3) Are CaPcoated chitosan-based scaffolds able to enhance osteogenic differentiation of rat MSCs compared with uncoated (without CaP coating) scaffolds?
Materials and Methods

Materials
In this work, degradable scaffolds based on chitosan and corn starch were developed. Two different compositions were prepared using a precipitation method 7 : chitosan (Ch) and chitosan=starch (CS) scaffolds. Briefly, chitosan was dissolved in acetic acid 1% (v=v) to obtain a 5% (w=v) solution. Then, using the same procedure, another formulation was prepared with the following ratio: 60=40 chitosan=starch. The chitosan and chitosan=starch solutions were cast into molds and frozen (À188C) overnight. 6 They were then immersed in a precipitation solution (25% (v) NaOH 1 M and 75% (v) Na 2 SO 4 0.5 M) overnight, adapted from Tuzlakoglu et al. 7 After precipitation, the samples were washed several times with distilled water to remove excess salt from the precipitation solution. After this procedure, two other formulations were prepared based on biomimetic coating methodology, 31, 32 consisting of an impregnation of the materials with bioactive glass called Bioglass Ò (45S5) supplied by NovaMin Technology (Alachua, FL) followed by an immersion in a simulated body fluid (SBF, 378C, pH 7.4), presenting ionic concentrations similar to human blood plasma. Briefly, chitosan (Ch) and chitosan=starch (CS) scaffolds were immersed in a wet bed of bioglass for 6 h in a rotator. After that, the scaffolds were immersed in simulated body fluid (1.0 SBF) solution with lysozyme (1 g=L) for 7 days at 378C (nucleation stage). This stage allows for the formation of CaP nuclei. After the nucleation stage, all samples were washed with distilled water and immersed in a concentrated simulated body fluid solution (1.5 SBF) for 7 days at 378C to enhance CaP nuclei growth. Two different samples were obtained after the biomimetic coating technique: CaP chitosan scaffolds with incorporated lysozyme (CaP=Ch þ lysozyme) and CaP chitosan=starch scaffolds with incorporated lysozyme (CaP=CS þ lysozyme). 33 
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Degradation studies
Degradation studies were performed in triplicate by incubating the chitosan scaffolds (Ch) in phosphate-buffered saline (PBS) solution (pH 7.4) with lysozyme (1.5 g=L), a concentration similar to the ones incorporated into CaP biomimetic coatings, at 378C up to 21 days. Lysozyme solution was changed every 7 days. At the end of the degradation period, the samples were removed, washed with distilled water, and dried in a graded series of ethanol for later calculation of weight loss. The porosity, pore interconnectivity, pore size, and 3D structures of dry chitosan scaffolds were analyzed before and after degradation by microcomputed tomography (m-CT).
Microcomputed tomography
The scaffolds were analyzed using m-CT before and after degradation with lysozyme for the different periods of immersion (0, 3, 14, and 21 days). m-CT was carried out using a Skyscan 1072 (Skyscan, Kontich, Belgium) (pixel size resolution of 6.59 mm), with X-ray source settings of 40 keV and 250 mA. The data sets were acquired over a rotation range of 1808 (0.458 rotation step) and reconstructed with software (NRecon v1.4.3; SkyScan). Representative data sets were segmented with a dynamic threshold of 40-255 and were used for morphometric analysis (CT Analyser, v1.5.1.5; SkyScan) and to build the 3D models (ANT 3D creator, v2.4; SkyScan). The morphometric analysis included porosity, pore interconnectivity, mean pore size, and mean fiber thickness. Three-dimensional virtual models of representative regions in the bulk of the scaffolds were created, visualized, and registered using both image processing software packages to access the morphological changes after degradation (CT Analyser and ANT 3D creator). The interconnectivity was quantified as the accessible void fraction over a range of minimum connection sizes using an analysis software tool (CT Analyser, v1.5.1.5; SkyScan). A 3D shrinkwrap process was performed to shrink the outside boundary of the volume of interest (VOI) in a scaffold through any openings whose size was equal to or larger than 53 mm. Any void space connected via interconnects below this size was considered to be inaccessible, 34 based upon reported minimum pore interconnection sizes for bone tissue ingrowth. 35, 36 Interconnectivity was calculated as follows 37 :
where V t is the total volume of the VOI, V sw is the VOI volume after 3D shrink-wrap processing, and V m is the volume of scaffold material. The wall thickness was defined as the pore wall thickness and was quantified with m-CT analysis based upon structural indices using a software tool (CT Analyser, v1.5.1.5; SkyScan). Specifically, quantitative analysis of the pore wall thickness was retrieved from the 3D analysis using structure thickness parameters.
MSCs isolation
Rat MSCs were obtained from femurs and tibias of 41-44-day-old male Wistar rats (Charles River Laboratories, Wilmington, MA) using the method described by Maniatopoulos et al. 38 The harvested cells were cultured until confluence in a humidified atmosphere with 5% CO 2 at 378C. Nonadherent cells were removed after 1 and 3 days. Upon reaching confluence, the cells were trypsinized, centrifuged, and resuspended in a known amount of medium and 10% dimethyl sulfoxide to obtain a final concentration of 3Â10 6 cells=mL. This cell suspension was then aliquoted into cryotubes for storage in liquid nitrogen (*1 mL=cryotube).
Cell seeding
Chitosan-based scaffolds with 6 mm diameter and thickness of 0.8-1.0 mm were press fit into 6-mm-diameter cassettes and covered with complete osteogenic medium [a-MEM supplemented with 10% fetal bovine serum from Cambrex=BioWhittaker (Walkersville, MD), 50 mg=mL gentamicin, 100 mg=mL ampicilin, 10 mM fungizone, 50 mg=mL L-ascorbic acid, 0.01 M b-glycerophosphate, and 10 À8 M dexamethasone] overnight. After 1 day, each scaffold was seeded with 280,000 cells contained in 100 mL of complete osteogenic media in accordance with previous studies. 39, 40 Three hours after cell seeding, 10 mL of complete osteogenic media was added to each well of a six-well plate. After 24 h of attachment, the scaffolds were placed in new six-well plates for 8, 16 , and 21 days with complete osteogenic medium. Media were changed every 3 days. Each group consisted of n ¼ 6 samples.
At the end of each culture period, samples were removed from the cassettes and rinsed with PBS solution. Three samples from each group were stored at À208C in ddH 2 O until analyses were performed. One of the remaining three samples was immersed in PBS with calcein-AM for 45 min for observation under confocal microscopy, and the other two samples were fixed with 2.5% glutaraldehyde for Fourier transformed infrared spectroscopy (FTIR) analysis and for observation under scanning electron microscopy (SEM).
DNA analysis
Measurement of the cell number in chitosan-based scaffolds was assessed from cell lysates using the Picogreen dsDNA Quantification Kit according to the instructions of the manufacturer (Molecular Probes, Eugene, OR). All standards and samples were prepared in triplicate. The fluorescence at 545 nm was read on a plate reader (FLx800; Bio-Tek Instruments, Winooski, VT) to determine DNA concentrations per scaffold. The cellularity of each scaffold was calculated by correlation with the DNA concentrations measured from a known number of MSCs.
Alkaline phosphatase activity measurements
Alkaline phosphatase (ALP) activity assays were performed on cell lysates using an established protocol. 39 All reagents were purchased from Sigma (St. Louis, MO). All samples were prepared in triplicate and compared against pnitrophenol standards. The reaction was stopped by adding 100 mL of 0.3 N NaOH. Absorbance was read at 405 nm on a plate reader (PowerWave Â340; Bio-Tek) to determine the ALP activity per scaffold.
Calcium deposition measurement
Calcium deposition measurements were made in triplicate. CaP-coated chitosan-based scaffolds with incorporated
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lysozyme without cells at the end of each time period were used as controls to determine the calcium content of the coating. Then, these values were subtracted from the calcium content obtained by CaP-coated chitosan-based scaffolds with incorporated lysozyme cultured with cells to normalize the data. Calcium deposition was evaluated using a calcium assay from Diagnostic Chemicals (Oxford, CT). After ALP and DNA assays were completed, a volume of 1 N acetic acid equal to the remaining volume was added to each well (for a final concentration of 0.5 N), and the plate was placed on an orbital shaker overnight. A volume of 300 mL of calcium assay reagent was added to 20 mL of sample solution in 96-well plates. All samples were assessed in triplicate. To generate a standard curve, serial dilutions of CaCl 2 were prepared (0-50 mg=mL). Absorbance was read at 650 nm with a spectrophotometer plate reader (PowerWave Â340; Bio-Tek). The calcium deposition in each scaffold is reported as mg Ca 2þ .
Microscopy analysis
After each time period, chitosan-based scaffolds were removed from the cassettes, washed with PBS, and stained with calcein-AM (Molecular Probes) according to the manufacturer's instructions. After 45 min immersion in PBS with calcein-AM, images were recorded using a laser scanning confocal microscope with a 10Â APO objective (Zeiss LSM 510 Axiovert; Carl Zeiss, Oberkochen, Germany). Samples for SEM were washed twice in PBS and fixed with 2.5% glutaraldehyde for 30 min. Then, the scaffolds were washed with PBS and dehydrated in a graded series of ethanol, and dried after immersion in hexamethyldisilazane.
FTIR with attenuated total reflectance
Chitosan-based scaffolds before (control samples) and after 16 days of culture were analyzed by FTIR-attenuated total reflectance (ATR). The scaffolds were fixed in 2.5% glutaraldehyde, dehydrated in a graded series of ethanol, and dried at room temperature. All spectra were recorded using 64 scans and 4 cm À1 in an FTIR spectrophotometer (IR Prestige-21, Fourier Transformer infrared spectrophotometer; Shimadzu, Kyoto, Japan).
Statistics
Results of DNA, ALP, and calcium assays are expressed as mean AE standard deviation with n ¼ 3 for each group. Statistically significant differences were determined using Student's t-test multiple comparison procedure at a confidence interval of 95% ( p < 0.05).
Results and Discussion
Degradation studies
The degradation of chitosan in the human body has been reported to be carried out by lysozyme. 16, 17 Previous studies have identified the optimal concentration of lysozyme for the degradation of chitosan-based scaffolds in vitro to be 1.5 g=L. 33 Accordingly, a lysozyme concentration of 1.5 g=L was used in the present study for optimal degradation of the chitosan-based scaffolds, as well as to approximate the 
FIG. 5. Laser scanning confocal microscope images of cells stained with calcein-AM at the top surface of scaffolds after 8 days: (A) chitosan (Ch), (B) CaP-coated chitosan scaffolds with incorporated lysozyme, (C) chitosan=starch (CS), and (D)
CaP-coated chitosan=starch scaffolds with incorporated lysozyme. All images obtained 45 min after incubation with calcein-AM using a 10Â APO objective. The scale bar is 100 mm and applies to all images. Rat MSCs adhered to all scaffold formulations and maintained viability after 8 days of culture, with no differences observed among the groups.
concentration of similar enzymes previously incorporated into biomimetic CaP coatings 22 and the concentration of lysozyme incorporated into the CaP coatings in the present study. 39, 40 As observed in Figure 1 , chitosan scaffolds were degraded gradually as a function of immersion time in lysozyme solution (1.5 g=L). The weight loss (%) after 3, 7, 14, and 21 days was 11.6 AE 0.5, 14.9 AE 0.4, 15.6 AE 0.4, and 18.2 AE 1.1, respectively (Fig. 1) . This gradual weight loss is confirmed by images obtained by m-CT, where an almost nonporous structure before degradation was observed ( Fig. 2A) with a significant increase in porosity after different time periods, being obvious after 14 days (Fig. 2D ) and 21 days (Fig. 2E ). These results demonstrate the ability of lysozyme to induce degradation and subsequent formation of pores into chitosan scaffolds. Enzyme-independent starch erosion might have contributed to the scaffold degradation observed in the present study. Although minimal enzymeindependent erosion was expected, the erosion of starch from chitosan=starch scaffolds in the absence of lysozyme was not examined in the present study and will be investigated in future studies. As the present study established that lysozyme in solution at a concentration similar to the concentration incorporated into the CaP coatings enhances pore formation and interconnectivity with time, future studies will examine the degradation of CaP-coated chitosan scaffolds with incorporated (i.e., entrapped) lysozyme.
Upon analyzing the images of chitosan (Ch) scaffolds obtained by m-CT, it is possible to see the increase of porosity as a function of immersion time (Fig. 2) . The control scaffolds (before degradation) presented *5% porosity. According to Figure 3A lysozyme enhanced the porosity of the scaffolds as a function of degradation time. After different time points, lysozyme had a significant effect on chitosan scaffolds, inducing the formation of a porous structure (Figs. 2 and 3A) . Further, the interconnectivity of chitosan scaffolds increased significantly after 21 days (Fig. 3B) . Moreover, the effect of lysozyme was also detected in pore size and wall thickness results (Fig. 4A, B) , where a significant increase in size of pores (Fig. 4A) and a significant decrease of wall thickness (Fig. 4B) were evident compared with control scaffolds (before degradation). These results were expected since after different periods of degradation with lysozyme the formation of pores was observed, evidencing a significant increase of porosity as a function of degradation time *5-55% (Fig.  3A) up to 21 days, resulting in porous 3D structures with interconnected pores (*78%). The observed increase in scaffold porosity and pore interconnectivity could be due to an increase in the size of existing pores, the formation of new pores, or a combination of the two mechanisms. However, the exact mechanism by which the scaffold porosity and pore interconnectivity increased in the present study was not elucidated.
Assays
Confocal microscopy images after 8 days show that rat MSCs were able to adhere to all scaffold formulations and maintain their viability. Cells covered the surface of all scaffolds, and no differences can be observed among groups (Fig. 5) .
Scaffold cellularity is presented in Figure 6 . It should be noted that for cases in which cells were completely entrapped within ECM produced during culture, such that the DNA therein could not be fully liberated for inclusion in the lysate for assessment of cellularity, then the measured results may reflect an underestimation of the actual number of cells on=within the scaffold, especially at later time points. However, an increase in cell number indicating cell proliferation was observed between days 16 and 21 for all groups. The number of cells after 8 days was lower than was expected, except for CaP-coated chitosan=starch with incorporated lysozyme. This can be related to the small surface area of scaffolds where cells were seeded and explained by a lack of initial porosity in these scaffolds. However, after 21 days, a significant increase was observed in the number of cells for CaP-coated chitosan scaffolds with incorporated lysozyme, which corresponds to the increase in porosity as a function of time, as was shown in the degradation results (Fig. 1) . During the time of culture with MSCs, it was expected that lysozyme would be able to degrade CaP-coated chitosanbased scaffolds, inducing the formation of pores by lysozyme and allowing the penetration and colonization of cells into the scaffolds, as shown in Figure 7B after 21 days.
The use of biomimetic coating methodology in this study allowed the incorporation of lysozyme that will be able to degrade chitosan-based scaffolds. It is expected that CaP coatings will enhance the osteoconductive properties of the resulting materials. The SEM images after 8 days show cells attached to scaffold surfaces; however, after 16 and 21 days all surfaces were completely colonized by the cells, and after 21 days mineralized matrix was observed on CaP-coated chitosan-based scaffolds (Fig. 7A) , clearly visible at high magnifications for scaffolds with incorporated lysozyme (Fig. 7B) . These results corroborate the calcium content measurements, where calcium was detected after 16 and 21 days (Fig. 8) . Additionally, small pores were observed in the dense layer for CaP=CS þ lysozyme at high magnifications (Fig. 7B) .
ALP is an enzyme expressed by cells and is an early marker of osteoblastic differentiation in MSCs. 41 CaP=CS þ lysozyme and uncoated scaffolds (Ch and CS) reached their maximum measured ALP activity on day 8 and 16, respectively (Fig. 9) , reflecting the early osteogenic differentiation stage of the MSCs. The highest value of ALP activity for CaP=Ch þ lysozyme was obtained at day 21; however, the difference between the 16th and 21st days was not statistically significant.
Calcium deposition is an indicator of the level of mineral deposition, which is a marker of the full maturation of osteoblastic cells. No calcified ECM deposition was observed at day 8 (Fig. 8) . After 16 days, calcium deposition was detected for CaP-coated chitosan-based scaffolds with incorporated lysozyme. At the end of the third week, the calcium measurements indicated the deposition of significant amounts of mineralized matrix for all scaffolds, with a significant increase for CaP-coated chitosan-based scaffolds with incorporated lysozyme (Fig. 8) . The amount of calcium detected on CaP-coated scaffolds was higher for both time points of CaP=Ch þ lysozyme; however, when comparing cellularity (Fig. 6) , it is apparent that the number of cells was also higher, indicating that the lower number of cells present in CaP=CS þ lysozyme also was able to produce mineralized ECM. Nevertheless, when comparing the number of cells present in these two scaffolds with the calcium content, both scaffolds had a similar effect on the cells. Indeed, comparison of cellularity results (Fig. 6 ) and ALP activity results (Fig. 9 ) reveals that the maximum ALP activity occurred at either day 16 or 21 for all groups except the CaP=CS þ lysozyme group. As ALP activity is an early marker of osteoblastic differentiation of cells, and as cellular differentiation and proliferation are inversely proportional, it follows that a minimum in cellularity at day 16 may reasonably correspond with a peak in ALP activity at day 16. Further, the presence of mineralized matrix, as measured by calcium content of constructs, increased with time for all groups, indicating the osteogenic differentiation of cells in all groups, although this effect was most pronounced in the CaP-coated scaffolds with incorporated lysozyme.
FTIR with ATR
When FTIR-ATR spectra of controls (without cells) of chitosan (Ch) and chitosan=starch (CS) scaffolds were analyzed, the characteristic bands of chitosan (1150-890 cm À1 ) were detected (Fig. 10A, C) . After 16 and 21 days of culture (Fig. 10A, C) , these spectra showed the presence of amide bands: 1650 cm À1 (amide I) and 1542 cm À1 (amide II), which can be related to protein matrix formation. Carbonate groups at 1500-1418 cm À1 were also detected (Fig. 10A, B) . These carbonate groups are related to carbonate apatite, one of the CaPs present in bone tissue, suggesting the presence of mineralized ECM. Presented in Figure 10B and 10D are the spectra of CaP=Ch with incorporated lysozyme and CaP=CS with incorporated lysozyme scaffolds. In FTIR-ATR spectra of the CaP-coated chitosan-based scaffolds when lysozyme was incorporated, the presence of amide I and amide II in uncultured scaffolds (controls) was detected (Fig. 10B, D) . The amide I band represents the stretching vibrations of C ¼ O bonds in the backbone of the protein. 42 Further, the amide II band arises from the combination of C-N stretching and N-H bending vibrations of the protein backbone. 42 These bands obtained in the case of the control samples could indicate the adsorption of lysozyme on the surface of chitosan and chitosan=starch scaffolds. However, an increase of intensity of these bands was observed as a function of culture time (Fig. 10B, D) . As previously mentioned, these might indicate a protein matrix formation. In the spectra of control 
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scaffolds (Fig. 10B, D) , carbonate bands (1500-1418 cm À1 ) were also detected, which are associated with CaP coating on the surface of the scaffolds. In addition, these bands became more intense with culture time, suggesting the formation of mineralized ECM. However, phosphate bands (1190-976 cm
À1
) were not clearly detected, which was likely related to overlapping with the polysaccharide ring band of chitosan (1150-890 cm À1 ). FTIR-ATR results confirm the results of calcium measurements, clearly suggesting protein matrix formation and the presence of mineralized ECM. Further, these results suggest that the mineral formed by rat MSCs cultured for 16 and 21 days is carbonate apatite mineral similar to the major mineral component of bone. Future studies will build upon the results from the present study, which demonstrates that lysozyme has an effect on pore formation in chitosan scaffolds and osteogenic differentiation of MSCs, and will focus upon the use of different concentrations of lysozyme and characterization of the actual lysozyme content of the scaffolds.
Conclusions
The degradation studies performed with lysozyme using similar concentration to those incorporated into CaP coatings showed the formation of pores as a function of immersion time, indicating an increase of porosity *5-55% up to 21 days. Lysozyme had a significant effect on chitosan scaffolds resulting in porous 3D structures with interconnected pores (*78%). On the basis of these studies it was concluded that CaP biomimetic coatings with incorporated lysozyme enhance osteogenic differentiation of rat MSCs. Therefore, the use of CaP biomimetic coating strategy with incorporated lysozyme on the surface of chitosan-based scaffolds provides an improved environment for rat MSC differentiation along the osteogenic lineage when compared with uncoated scaffolds, as was shown by calcium deposition measurements and FTIR-ATR results, indicating the production of mineralized ECM. The demonstrated ability of these novel surfacecoated scaffolds to form an interconnected pore structure in situ coupled with the positive effect of these scaffolds on the osteoblastic differentiation of MSCs and mineralized matrix production clearly illustrate the strong potential of these scaffolds for application in bone tissue engineering strategies.
